Top Markets
Coin of the day
IGEA Pharma N.V. IGEA Pharma N.V.

IGEA Pharma N.V.

IGPH
Rank in Stocks #40706
IGEA Pharma N.V. specializes in marketing health and medical technology... IGEA Pharma N.V. specializes in marketing health and medical technology products and devices across the United States and the Netherlands. Its product portfolio features Alz1, a home-based diagnostic kit for measuring non-bound copper in the bloodstream, alongside Alz1 Tab dietary supplements formulated to decrease heavy metal levels in the blood. The company also offers a rapid test for COVID-19, which identifies IgM and IgG SARS-CoV-2 antibodies. Additionally, it provides dry aerosol generators for sanitizing air and inanimate surfaces, as well as equipment for air purification and sterilization. The company also performs laboratory analysis services. Founded in 2015, IGEA Pharma N.V. maintains its primary offices in Hoofddorp, the Netherlands.
Share Price
$0.00057292
Last synced: 2023-12-04
Market Cap
$95.08K
Change (1 day)
0.59%
Change (1 year)
0.00%
Country
NL
Trade IGEA Pharma N.V. (IGPH)

Category

Revenue for IGEA Pharma N.V. (IGPH)
Revenue in Aug 2026 TTM: 0
According to IGEA Pharma N.V. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for IGEA Pharma N.V. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.34B -
US
$25.11B -
US
- -
CN
$2.71B -
US
$4.55B -
US